Stay updated on ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Sign up to get notified when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new site revision marker 'Revision: v3.6.5' is displayed, and the link to the plain language summary of the study on the Trial Results Summaries site has been removed.
    Difference
    0.1%
    Check dated 2026-08-10T13:24:52.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page revision has been updated to v3.6.4, replacing the previous v3.6.3, indicating a small update to the page’s underlying version rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-07-27T06:23:05.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a statement that anonymized individual participant data will not be provided for this trial and directed readers to the data sharing policy. Previous IPD sharing links and related information were removed.
    Difference
    0.7%
    Check dated 2026-07-20T01:09:48.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new Revision: v3.6.3 label is now shown, replacing the previous Revision: v3.6.2, indicating a small update to the page's revision information.
    Difference
    0.0%
    Check dated 2026-07-05T12:29:49.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    - The page's revision stamp was updated from v3.6.0 to v3.6.2, reflecting a newer build of the ClinicalTrials.gov interface for this study record.
    Difference
    0.0%
    Check dated 2026-06-28T08:18:31.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now includes a recruitment status notice No longer looking for participants and adds new user-help sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment header formatting was adjusted and the page revision label updated from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-14T03:42:38.000Z thumbnail image

Stay in the know with updates to ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.